Some are designed mainly for appetite control, others for blood-sugar regulation, and some for both
Semaglutide and other GLP-1 agonistsmedications that bind to GLP-1 receptors and mimic their effectsare currently used as treatments for diabetes and obesity
Bone (2015) 81:45967.10.1016/j.bone.2015.08.006 31 IepsenEWLundgrenJRHartmannBPedersenOHansenTJorgensenNRet alGLP-1 receptor agonist treatment increases bone formation and prevents bone loss in weight-reduced obese women
These mood changes often drive continued use as people attempt to self-medicate emotional discomfort
If you're in the Chicago western suburbs and want comprehensive, evidence-based care from a triple board-certified endocrinologist, here's what to expect
Your Patient Care Coordinator is available for scheduling appointments, questions, phone calls and even texting